Wells Bio
Wells Bio developed careGENE™ COVID-19 RT-PCR kit, an in vitro diagnostic medical device for qualitative detection of novel coronavirus (COVID-19) from RNA extracted from human Nasopharyngeal swab, Oropharyngeal swab and sputum using real-time RT-PCR (Reverse transcription-Polymerase Chain Reaction).